NCT02527941View on ClinicalTrials.gov

Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Bacterial VaginosisHIV Infections
Interventions
DRUG

Metronidazole

Participants will be provided with oral metronidazole 400mg po tid for one week, and followed up one month after treatment initiation.

Trial Locations (1)

Unknown

Kenya AIDS Vaccine Initiative Clinic, Nairobi

All Listed Sponsors
lead

University of Toronto

OTHER

NCT02527941 - Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology | Biotech Hunter | Biotech Hunter